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A B S T R A C T
Background: Conventional cancer treatment methods suffer from many limitations such as non-specificity in
discrimination between healthy and malignant cells. The aim of this study was to investigate the role of poly-
meric gold-photoactive nanoparticles (PGPNPs) conjugated with folic acid (FA) as theranostic nanoparticles for
active targeting, real-time fluorescence tracing and radiosensitivity inducition in LNCaP prostate cancer cells.
Methods: The cellular uptake and cytotoxicity effect of gold nanoparticles (PGPNPs and PGPNPs-FA) after 2 and
24 h treatment were evaluated in in both cancer (LNCaP) and normal (HUVEC) cells using fluorescent micro-
scopy, Induced coupled plasma optical emission spectrometry (ICP-OES) and Tetrazolium bromide dye (MTT),
respectively. The therapeutic efficacy was analyzed on the LNCaP cells. For this purpose, LNCaP cells were
treated by nanoparticles and ionizing radiation, and the synergistic effect of treatment methods were evaluated
by colony formation assay (CFA) and Flow cytometry analysis.
Results: The results of fluorescence imaging and ICP-OES data showed that the LNCaP cells absorbed PGPNP-FA
nanoparticles more than PGPNP (P < 0.001). Also, the uptake of nanoparticles was significantly greater in
cancer cells than in healthy ones (P < 0.01). MTT assay results indicated higher cytotoxic effect of nano-
particles conjugated with FA in folate-receptor overexpressing LNCaP cancer cells compared to HUVEC normal
cells (P < 0.01). Furthermore, CFA and Flow cytometry results demonstrated that combinatorial therapy of
polymeric gold nanoparticles with/without FA and ionizing radiation at various doses (2, 4 and 6 Gy) had a
synergistic effect on survival fraction and induction of apoptotic and necrotizing cell death (P < 0.01).
Conclusion: PGPNPs-FA nanoparticles led to higher and more specific uptake and accumulation of nanoparticles
in LNCaP cells, thereby increasing the ability of gold nanoparticles as radio-sensitizer.
1. Introduction
Prostate cancer (PCa) is the second common reason of death among
men around the world, which kills about 250,000 patients a year [1].
Surgery, chemotherapy and radiotherapy are commonly used methods
to treat this type of cancer. Non-specificity and the potential for severe
damage to healthy tissue is one of the most important problems in
routine treatments [2]. Generally, more than 50 % of patients are
treated with radiation therapy, which has limitations in achieving high
dose to the tumor area and the protection of the healthy tissue sur-
rounding the tumor. There are two main strategies to these challenges:
the use of radio screensavers or the use of radio sensors [3]. Recently,
new technologies have developed to overcome such limitations where
nanotechnology role seems the most important [4]. Nanomaterials be-
came variously applied in clinic due to physical, chemical, optical and
size related properties such as high surface/volume ratio and bio-
compatibility [5]. Recent advances in nanotechnology has introduced
smart nanomaterials, applicable in active targeting approach. By
modifying the surface of nanoparticles with ligands whose receptors are
specifically over-expressed on the surface of the cancer cells, the an-
ticancer agents can be transmitted specifically to the tumor cells, which
is known as active targeting [6,7]. Targeted nanomaterial selectively
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binds to and affects cancer cells which made their application more
advantageous to compare with other treatment methods [8]. Folic acid,
an essential vitamin, has critical role in cell proliferation. Cellular
membrane of special cancer cell lines including head and neck, breast,
ovary, uterus and prostate express abundant folic acid receptors [9]. So
that combining folic acid with other therapeutic materials can facilitate
effective targeting of cancer cells [10]. Among targeting methods based
on physical and biological differences between healthy and cancer cells,
this method is used efficiently [11]. In dynamic targeting, in order to
increase the access of particles to desired tissue, a mixture of bound
ligands to particle surface with high affinity to distinct molecules is
used. Specific binding can facilitate ligand dependent endocytosed to
internalize particles into the cells [12]. Folate (acid folic salt) is one of
the required components in purine and pyrimidine biosynthesis in DNA
replication process [13]. Rapid cell division in cancer cells leads to
higher demand of folate and hence cancer cells express more folate
receptors [14]. Folate properties such as stability, easy combination,
lack of immune system simulation, higher specific receptor affinity
(Kd≈10-9) and rapid penetration to cancer cells made it suitable ele-
ment for targeting approach [14,15]. Recently, the use of gold nano-
particles modified with folic acid has been considered as an effective
factor in targeted radiation therapy. But it will be even more interesting
to use nanoparticles for tracking, sensing or labeling [16].
Gold Nanoparticle (GNPs) is one of the best options in cancer
treatment since it is biocompatible, easy to synthesis, chemo-physical
stable and own adjustable optical properties [17]. Recently, gold na-
noparticle was introduced as radio-sensitizers [18]. Both the physical
and the biological aspects are important to understand the radio-
sensitivity of the gold nanoparticles. In addition to the high atomic
number, the radius of a sensitizer agent also directly affects radio-
therapy yield by effecting on photoelectric cross-section collision [19].
Based on this physical reality, ionizing radiation intensely absorbs by
gold nanoparticles possessing high atomic number (Z= 79). GNPs also
show a high radiation sensitivity due to a greater atomic radius than
gold atom (∼0.17 nm) [20]. In addition to sensitizing radiation prop-
erties of gold nanoparticles, it has recently reported that bound folate to
gold nanoparticles can be applied as an effective agent in targeting
radiotherapy [21]. Gold nanoparticles bound to folic acid thorough
receptor dependent endocytosis, enters those cells that express folic
acid receptor on their cell surface. Moreover, the internalization, in
order to achieve efficient therapy beside targeted one; nanoparticles
aggregation inside cancer cells has to increase specifically. For this
purpose, binding to biological molecules like folate is possible [16].
Fluorescent microscopy is an efficient tool in live cell and tissue
imaging, which unlike other techniques, is capable of dynamic imaging
of live cell processes. Spiropyran derivatives are the most suitable
photochromic organic compounds [22]. Fisher discovered Photo-
chromic properties of Spiropyran in 1952 [23]. These characteristics
are present in soluble phase. Spiropyran molecule in closed form is
nonpolar and consists of two perpendicular halves. Thus, less pairing
happens between these halves, it remains colorless and called Spiro (SP)
form. The carbon-oxygen bond breaks upon UV radiation [24]. Thus, in
Spiropyran derivatives, radiation cause reversible break in CO bond
opens colorless, non-polar ring of SP and turns it to Merocynanin (MC)
isomer that is in contrast, colorful and polar. So, SP is used as fixed
colorful Merocynanin in polymer form for optical imaging [25]. In this
paper, we attempted to study the role of polymeric gold nanoparticles
as fluorescent carrier in homocysteine bed for tracing and radio-sensi-
tizing according to acid folic and gold nanoparticles effects. Here, the
influence of presence and absence of acid folic was studied on prostate
cancer cells (LNCaP) in comparison with healthy cells (HUVEC). Con-
sidering applied fluorescence nature of the nanoparticle, the nano-
particle presence can be analyzed by optical imaging in every stage.
2. Material and methods
2.1. Material
All materials, reagents and solvents for synthesis of nanoparticles
were supplied by Merck and Sigma-Aldrich (Germany) except for 2,2-
Azobis [2-(2- imidazoline-2-yl) propane] dihydrochloride (VA-044),
that was obtained from Wako Pure Chemical Industries Ltd (Osaka,
Japan). LNCaP and HUVEC cell lines derived from the human prostate
adenocarcinoma was purchased from the cell bank of the Pasteur
Institute of Iran. Cell culture medium (RPMI), Fetal bovine serum (FBS)
and Penicillin-Streptomycin were purchased from Atocel (Austria).
2.2. Synthesis of folic acid conjugated polymer coated gold photoresponsive
nanocomposites (PGPNPs-FA)
The synthesis of polymeric gold nanoparticles was carried out in
three steps:
2.2.1. Preparation of photo responsive latexes containing Spiropyran and
Imidazole (PNPsIm)
Preparation of Spiropyran photochromic compound was performed
according to the previously reported procedure [22]. Semi-continuous
emulsion polymerization method was used to prepare polymeric na-
noparticles containing photochromic compound in the inner parts and
n-vinyl imidazole monomer in the outer part. For this purpose, 70 ml of
aqueous solution of cetyl trimethyl ammonium bromide as a cationic
stabilizer (CTAB, 300mg), and 60mg of VA-044 initiator were prepared
and transferred to the three-necked round bottom reactor. Then, 20ml
of Spiropyran acid ethyl acrylate monomers (SPEA, 200mg) solution
and 5.7 ml of methyl methacrylate monomer (MMA) were added to the
reaction vessel. Next, the mixture of monomers of MMA (1.5mL) and N-
vinyl imidazole (NVIM, 0.2mL) were added to the reaction vessel
dropwise.
2.2.2. Preparation of the polymer-gold photoresponsive nanocomposites
(PGPNPs)
After preparation of functionalized latexes containing Spiropyran
and Vinyl imidazole, the chloride Au3+ ions were deposited on the
surface of polymeric nanoparticles (PNPsIm) using in situ reduction
method. For this purpose, 65ml of HAuCl4.3H2O (3 g/L) was added to
35ml of the prepared latex (prepared previous step) and stirred for
24 h. Then, 23ml of sodium borohydride (3 g/L) were added dropwise
and the stirrer continued for 1 h. At last, as the reaction progressed, the
color of the mixture changed from yellow to violet [21].
2.2.3. Preparation of the polymer-gold photoresponsive nanocomposites
functionalized with folic acid (PGPNPs-FA)
The L-cysteine was used for conjugation of the folic acid compound
to the surface of gold nanoparticles as an intermediate. Initially, the
mixture of folic acid (250mg, 0.57mmol) and 4-(dimethylamino)
pyridine (DMAP) (18mg, 0.15mmol) were added to anhydrous di-
methyl sulfoxide (DMSO) and stirred at room temperature for one hour.
N, N′-dicyclohexylcarbodiimide (DCC) (118mg, 0.57mmol) was then
dissolved in 10ml of dichloromethane (DCM) and solution was added
to the reaction mixture. After one hour, 69mg L-cystine (0.57 mmol) in
DCM (10ml) was added dropwise to the reaction vessel, the stirrer
continued for 24 h. Then, DCM (100mL) was added to the above so-
lution, centrifuged and the reaction precipitate was isolated. After,
150mg of the obtained product (FA-Lcys) was dissolved in distilled
water (20ml), and the ammonia solution was added to the reaction
solution to neutralize pH. The obtained solution was added dropwise
into the 30ml of the previously prepared latex containing polymer-gold
photo responsive nanocomposites (PGPNPs) and the mixture was
stirred for overnight. Finally, after purifying the PGPNPs-FA with a
dialysis bag, the nanoparticles were dried via freeze-drying.
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2.3. Characterization of nanoparticles
Dynamic light scattering analysis was used to characterize the dis-
tribution of the hydrodynamic size and diameter of nanoparticles
(PGPNPs and PGPNPs-FA). Also, the surface charge of nanoparticles
was investigated by Zeta sizer (Nanoflex, Germany). The morphological
investigation of the both nanoparticles was obtained using a
Transmission electron microscope (TEM, Zeiss LEO906, Germany). The
samples were prepared on 400-mesh carbon coated copper grid.
2.4. Biological experiments
2.4.1. Cell culture procedure
LNCaP human prostate cancer cells and HUVEC human umbilical
vein endothelial cells were cultured in a complete RPMI and Ham's F-12
medium supplemented with 10 % FBS, penicillin (100 U/mL) and
streptomycin (100mg/mL) at a concentration of 10,000 cells/cm2
within humidified incubator with 5 % carbon dioxide at 37 °C, re-
spectively.
2.4.2. Cellular uptake of Nanoparticles (PGPNPs and PGPNPs-FA)
Targeted transfer efficiency of nanoparticles in LNCaP cells with
high expression of folate receptors and HUVEC cells with low expres-
sion were investigated by two methods. A) qualitative method by
fluorescence microscopy and B) quantitative method by induced cou-
pled plasma spectroscopy.
2.4.2.1. Fluorescence microscopy. The confirmation of the entry of
nanoparticles into the LNCaP and HUVEC cells and tracing them in
two groups of nanoparticles with and without folic acid ligand was
performed at different incubation times 2 and 24 h. The cells were
seeded in 6-well plates at a density of 100000 cells/well in 1.5ml of
complete RPMI and Ham's F-12 medium. After 24 h, the medium was
removed and cells incubated with 0.01mg/ml of PGPNPs with/without
FA ligand for 2 h and 24 h. Then, the medium was removed and the
wells were washed twice with PBS. Cells were fixed with 2 %
formaldehyde for 30min. Fluorescence images of the cells were taken
with a fluorescence microscope (Olympus CK2; Olympus Optical Co.,
Tokyo, Japan). The wells are subjected to an excitation wavelength
(365 nm), and the emission wavelength of the sample was
550−560 nm.
2.4.2.2. Induced coupled plasma optical emission spectrometry (ICP-
OES). Two million LNCAP and HUVEC cells per wells were seeded.
After 24 h, the cells were treated with gold nanoparticles with/without
folic acid ligand for two times, 2 and 24 h. Then, the medium was
removed and the cells were harvested after 3 times washing with PBS.
Then, aqua regia solution (1–3 ratio of HNO3 65 % and HCl 37 %) was
added to samples at 140 °C for 1 h to digest all the nanoparticles and
cellular content. The amount of gold in the samples was determined by
ICP-OES assay (VISTAPRO, Varian, Australia).
2.5. In vitro cytotoxicity assay
The toxicity of the gold nanoparticles with and without folic acid
ligand was evaluated by the MTT cell viability assay. The LNCAP and
HUVEC cells were seeded in a 96-well microplate at a density of 8000
cells/well in 100 μl of complete medium. After 24 h, the cells were
treated with different concentrations (0−10mg/ml) of nanoparticles
(PGPNPs, PGPNPs-FA) for 2 and 24 h. Then, the MTT solution was
prepared (5mg/mL) in PBS. Wells washed twice with PBS for removal
of the nanoparticles. Then, 100 μl of the MTT solution was added to
each well and plates were incubated in incubator for 4 h. After, the MTT
solution was discharged and 200 μl of dimethyl sulfoxide (DMSO) was
added to each well. The plate was then incubated for 15−20min and
the absorbance (570 nm-test/630 nm-reference) was read by an ELIZA
reader. Finally, concentration via viability curves were obtained and
the half maximal inhibitory concentration (IC50) values were calcu-
lated.
2.6. Treatment with ionizing radiation
The irradiation of LNCaP cell line was performed using 6MV X-ray
photons with different doses (2, 4 and 6 Gy) at the Asia Hospital. The
radiation procedure was performed by a linear accelerator (Siemens,
Germany). To achieve the dosage of 4 and 6 Gys, the irradiation of the
cells with the dose of 2 was repeated two and three times. The flasks
were completely filled with complete RPMI culture medium (in order to
ensure the uniformity of radiation to the cells). The flasks were ar-
ranged side by side and irradiated with these conditions: Field dimen-
sions was 20×20 cm, the distance from the radiation source to the
bottom of the flask (Source surface distance) was 100 cm, the monitor
unit was 193 and the Gantry angle was 180 degrees.
2.7. In vitro antitumor efficacy of nanoparticles
2.7.1. Colony formation assay (CFA)
Colony formation assay was performed to evaluate the colony for-
mation ability of the LNCaP cells after treatments. For this purpose,
24 h after incubation, the cells were treated with (0.01mg/ml) of na-
noparticles (PGPNPs, PGPNPs-FA) only or combined with ionizing ra-
diation (2, 4 and 6 Gy), the cells were cultured in different concentra-
tions, and according to the doubling time of the cells, counting the
colonies were carried out after eight days. The colonies were fixed with
formaldehyde 2 % and stained with Crystal Violet color for 20min. The
efficiency of cell therapy was evaluated by calculating the plating ef-
ficiency (PE) by the following equation 1:
Plating efficiency (%)= (Number of obtained colonies/Number of
seeded cells) × 100 (1)
And the surviving fraction (SF) is also obtained by the following
equation:
Surviving fraction= (Plating efficiency of treated cells/Plating effi-
ciency of control cells) × 100 (2)
2.7.2. Cell apoptosis assay
Flow cytometry was used to determine the apoptotic death rate of
LNCaP cells induced by PGPNPs, PGPNPs-FA (0.01 mg/ml) and ionizing
radiation (2, 4 and 6 Gy), alone or in combination. After treatment, the
cells were harvested and trypsinized. Then, 1ml of 1X binding buffer
was added to cells (treated and untreated) and it was resuspended.
Next, 5 μl of Annexin FITC was added to each sample and incubated for
15min in dark conditions, at room temperature. Then 5 μl of Propidium
iodide (PI) was added and following that, the absorbance of the samples
was analyzed by a flow cytometer (BD, San Jose, USA).
2.8. Statistical analysis
All tests were repeated at least three times, and the results were
expressed as mean ± standard deviation (SD). For statistical analysis
of data, GraphPad Prism 6 was used. One-way ANOVA followed by
Tukey’s test were used to compare the groups. A value of P < 0.05 was
considered to be statistically significant.
3. Results
3.1. Characterization of nanoparticles
The average size of gold nanoparticles alone was about 12 nm, and
when added to the polymer, the average size of PGPNPs is about 47 nm.
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The results of the size distribution and surface charge of PGPNPs and
PGPNPs-FA nanoparticles are shown in Table 1. PGPNPs nanoparticles
had a size of 46.2 ± 0.92 nm and a Zeta potential of
-31.63 ± 0.02mV, which was 55.9 ± 0.06 nm and -28.85 ± 0.18mV
for PGPNPs-FA nanoparticles, respectively. Adding folic acid ligand
increased the size of the nanoparticles and decreased the absolute
magnitude of the zeta potential. Spherical morphology, uniform dis-
tribution, and size of nanoparticles based on TEM images are shown in
Fig. 1. The dark and light regions showed regions pointed by blue and
red arrows are related to Gold nanoparticles and polymer substrate,
respectively. The size of the nanoparticles obtained from the TEM
images was lower than that of the DLS analysis, which is due to the type
of preparation of samples used in two methods, in the TEM method, a
dry sample and in DLS method dissolved samples in aqueous phase are
used.
3.2. Confirmation of the entrance of nanoparticles to the cells
Targeted entrance of nanoparticles into the LNCaP and HUVEC cells
based on the fluorescence properties of nanoparticles were shown in
Fig. 2, qualitatively. According to the obtained images, the control
group of cells that have not uptake any nanoparticles lack fluorescence
radiation and the images were dark; on the contrary, the cells that have
uptake nanoparticles with folic acid exhibited the highest fluorescence
radiation (especially after 24 h of incubation). However, the results
showed that the rate of fluorescence was significantly higher in LNCaP
cells due to the higher expression of folic acid receptors at the cell
surface than in HUVEC cells (P < 0.001). Furthermore, the amount of
entered nanoparticles to the cells was measured by the amount of Au3 +
ions in pictograms per cell, using ICP-OES (Fig. 3). The amount of na-
noparticle uptake for two PGPNPs and FA-PGPNPs nanoparticles after
2 h incubation treatment based on Pg/cell was 0.02 ± 0.001 and
0.023 ± 0.001 Pg/cell, for HUVEC and 0.019 ± 0.002 and
0.041 ± 0.003 Pg/cell, for LNCaP cells respectively. The amount of
nanoparticle uptake for two PGPNPs and FA-PGPNPs nanoparticles
after 24 h incubation treatment based on Pg/cell was 0.081 ± 0.003
and 0.095 ± 0.001 Pg/cell, for HUVEC and 0.087 ± 0.002 and
0.25 ± 0.011 Pg/cell, for LNCaP cells respectively. As shown, the en-
trance of FA-PGPNPs nanoparticles after 24 -h treatment was sig-
nificantly higher than that of PGPNPs in both cells (P < 0.05). How-
ever, according to fluorescence imaging data (Fig. 2), the uptake of FA-
conjugated nanoparticles was significantly increased in LNCaP cancer
cells, which was 2.63-fold higher than in normal HUVEC cells
(P < 0.001). However, no similar effect was observed for PGPNPs
without folic acid ligand (Fig. 3). In addition, the nanoparticle entrance
was time-dependent and higher entrance was detected after 24 h in-
cubation compared to 2 h incubation.
3.3. Toxicity evaluation of PGPNP and FA-PGPNP nanoparticles on LNCaP
cells
The toxicity of PGPNP and FA-PGPNP nanoparticles on LNCaP and
HUVEC cells after 2 and 24 h of incubation was assessed by the MTT
cell viability assay. According to the results shown in Fig. 4, re-
presenting the percentage of live cells at the different concentrations of
the nanoparticle, the toxicity increases with increasing nanoparticle
concentration as well as the duration of treatment. Comparing the re-
sults of MTT assay for the treated cells with different types of nano-
particles showed that the gold nanoparticles conjugated with folic acid
are more toxic than gold nanoparticles without any conjugation
(P < 0.05, Fig. 4A & C). In addition, the IC50 values (the concentration
of nanoparticles, which cause 50 % death of cells) for both nano-
particles with different incubation times (2 and 24 h) were calculated
Table 1
Size and zeta potential of PGPNPs with and without FA ligand. (n=3,
mean ± SD).
Nanoparticles Particle size (nm) PDI ζ potential (mV)
PGPNPs 46.2 ± 0.92 0.16 −31.63 ± 0.02
PGPNPs-FA 55.09 ± 0.06 0.2 −28.85 ± 0.18
Fig. 1. TEM image and size distribution; A) Gold nanoparticles (PGPNPs). B) Gold nanoparticles modified with folic acid (PGPNPs-FA). The blue and red arrows
indicate the dark and light regions, that are related to Gold nanoparticles and polymer substrate, respectively.
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according to Fig. 4A & C. As shown in Fig. 4B, the IC50 values after 2 h
treatment of PGPNPs and PGPNPs-FA nanoparticles were equal to
0.358 ± 0.012, and 0.326 ± 0.021mg/ml for HUVEC cells and
0.427 ± 0.026, and 0.334 ± 0.017mg/ml for LNCaP cells, respec-
tively (Fig. 4B). It was found that there was no significant difference
among the cytotoxicity of PGPNPs and PGPNPs-FA in HUVEC cells
(P > 0.05), whereas the toxicity was significant in LNCaP cells
(P < 0.05). The IC50 values after 24 h treatment of PGPNPs and
PGPNPs-FA nanoparticles decreased to 0.24 ± 0.01, and
0.205 ± 0.004mg/ml for HUVEC cells and 0.28 ± 0.011, and
0.135 ± 0.006mg/ml for LNCaP cells, respectively (Fig. 4D). After
24 h treatment, the cytotoxic effect of PGPNPs-FA was significantly
higher than that of PGPNPs in LNCaP cells (P < 0.001) but there was
no significant difference between two type of nanoparticles in HUVEC
cells (P > 0.05), which indicated a remarkable potential for PGPNPs-
FA nanoparticles in targeting tumors.
3.4. Determination of the effect of PGPNG and FA-PGPNG nanoparticles or
their ionized radiation on LNCaP cells
The results of colony formation assay showed no significant differ-
ence in colonogenic death of cells of LNCaP between treated cells with
radiation (2 h and 24 h after treatment) compared to the control group
(P > 0.05, Fig. 5). However, colony formation assay showed that the
rate of colonogenic death increased by increasing ionized radiation
dosages (Fig. 5). These results were in accordance with the results of
flow cytometry test. According to the flow cytometry results, PGPNP or
2 Gy radiation did not induce any significant cell death when applied
alone (P > 0.05, Figs. 6 and 7).
Fig. 2. The nanoparticle uptake by LNCaP cells and HUVEC cells, using a fluorescence microscopy, the images related to the visible light and the images related to
fluorescence microscope are shown for control cells, PGPNP nanoparticles after 2 and 24 h’ incubation, and PGPNP-FA nanoparticles after 2 and 24 h’ incubation.
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3.5. Determination of the effects of PGPNG and FA-PGPNG nanoparticles
in combination with ionized radiation on LNCaP cells
Colony formation assay showed that the combined effect of radia-
tion and nanoparticles with/without FA during 2 h and 24 h after
radiotherapy significantly reduced cell survival fraction (P < 0.01,
Fig. 5). Also, according to the flow cytometry results, there was sig-
nificant difference in the amount of induced apoptosis by different
doses of ionized radiation in different time after radiation (P < 0.05).
The percentage of apoptosis deaths induced using PGPNPs and PGPNP-
FA nanoparticles in combination with different ionized radiation ranges
in both 2 -h and 24 -h after treatments were significantly increased
compared to the only ionized radiation in all three dosages of 2, 4 and
6 Gys (P < 0.05, Figs. 6 and 7). In addition, the percentage of cell
death was considerably increased by the use of PGPNP-FA nano-
particles compared to the use of PGPNP nanoparticles (P < 0.05). Fi-
nally, the results colony formation assay (Fig. 5) and Flowcytometry
(Figs. 6 and 7) indicate increased cell death in the combination of na-
noparticles (PGPNP and PGPNP-FA) and radiation, which could re-
present a significant potential for gold nanoparticles to improve
radiotherapy efficacy.
4. Discussion
Since the early 1960s, radiotherapy has been used as the main
treatment for advanced prostate cancer [26]. Although radiation dose
increases can kill cells, early and late side effects often limit the use of
Fig. 3. The amount of Au absorbed by LNCaP and HUVEC cells, 2 and 24 h after
treatment, using ICP-OES analysis, (Mean ± SD, n=3, statistical significance
was showed with (*) P < 0.05, (**) P < 0.01 and (***) for P < 0.001, re-
spectively).
Fig. 4. Cytotoxic effects of LNCaP and HUVEC cells treated with different concentrations of PGPNPs and PGPNPs-FA nanoparticles, A) 2 h and C) 24 h incubation.
The IC50 values of PGPNPs and PGPNPs-FA, B) after 2 and, D) 24 h of treatment. (Mean ± SD, n=3, statistical significance was showed with (*) P < 0.05, (**)
P < 0.01 and (***) for P < 0.001, respectively).
Fig. 5. The survival fraction of LNCaP cells after combinational therapy
(PGPNPs and PGPNPs-FA only or combined with radiation 2, 4 or 6 Gy) in
different groups. (Mean ± SD, n= 3, statistical significance was showed with
(*) P < 0.05, (**) P < 0.01 and (***) for P < 0.001, respectively).
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high radiation doses. Therefore, recent research is aimed at increasing
therapeutic efficacy in low doses of radiation [27]. Accordingly, in this
study the synergistic effect of radiosensitive gold nanoparticles medi-
ated with FA ligand was studied with the aim of enhancing the radia-
tion therapy efficacy in LNCaP prostate cancer cells.
In confirmation of past studies, our results showed that radiotherapy
of LNCaP prostate cancer cells using photonic energy of 6MV in dif-
ferent dosages increased clonogenic death immediately after treatment,
but has no significantly effect on apoptosis (P > 0.05). Bromfield et al.
(2003), has also evaluated ionizing radiations on apoptotic checkpoint
and cell cycle to analyze the main death mode in different prostate
cancer cell lines (LNCaP, DU145 and PC-3). Their results illustrated that
apoptosis induction due to ionizing radiation was minimal (6 %) after
radiation with dosage of 10 Gy. They have shown that apoptotic cell
death is not significantly related with clonogenic death and apoptosis is
not the main death mode caused by ionizing radiation [28]. Also, Ha
et al. has analyzed the expression of 84 effective genes in different
apoptosis pathways in LNCaP and PC-3 cell lines. The results showed no
significant changes in apoptosis induction after 10 Gy x-ray radiation
for both cell lines [29].
As explained in section 1, gold nanoparticles have a high potential
radiosensitizing, but this depends on different parameters, including
the size of the nanoparticles, cell uptaking, and the position of the
nanoparticles in the cell relative to the nucleus [30,31]. Cho et al.
(2009) and Ngwa et al. (2011) have argued that the accumulation of
gold nanoparticles of less than 100 nm in tumor cells, especially near
the cell nucleus, would increase cell death [32,33].
Therefore, in the first step, using fluorescence images and ICP-OES
data (Figs. 2 and 3), we proved that both synthesized nanoparticles
(PGPNP and PGPNP-FA) with a size less than 60 nm (Fig. 1) can enter
Fig. 6. A) The Annexin-V/PI staining assay for detecting the apoptosis of LNCaP cells. B) The percentage of apoptosis and necrotic cells, 2 h after treatment with
PGPNPs and PGPNPs-FA only or combined with radiation 2, 4 or 6 Gy. (Mean ± SD, n= 3, statistical significance was showed with (*) P < 0.05, (**) P < 0.01 and
(***) for P < 0.001, respectively).
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the LNCaP and HUVEC cells. However, as expected, the uptake rate due
to the Folic acid ligand was significantly higher for PGPNP conjugated
with FA in LNCaP cells (P < 0.01, Figs. 2 and 3). In addition, the re-
sults showed that PGPNP-FA nanoparticles were highly targeted to
LNCaP cancer cells compared to normal HUVEC cells.
Toxicity assay of nanoparticles showed that nanoparticles can de-
crease cell viability as well as cell growth trend. However, enhanced
cytotoxicity effect was obtained for FA-conjugated nanoparticles in
LNCaP cells compared to HUVEC cells (P < 0.001). This could be at-
tributed to the enhanced internalization of targeted PGPNP-FA by the
cancer cells, due to over-expression of folate-receptor on the surface of
cancer cells [34].
In the next step, the effects of combination therapy of radiation and
nanoparticles with/without FA on LNCaP cells were investigated, which
showed that gold nanoparticle application as radiosensitizer in LNCaP
cell line has increased clonogenic as well as apoptotic death in a dosage
dependent manner (Figs. 5–7). The presence of gold metal atoms with
high atomic number inside cells leads to secondary electrons produc-
tion due to radiation interaction to compare with particle absence [35].
Numerous studies have proved gold nanoparticles radio-sensitizing
property [36,37]. The disagreements between results of different stu-
dies can be caused by difference in concentration of gold nanoparticles,
type of nanoparticle coating as well as cell lines. However, few studies
were conducted in the field of sensitizing these nanoparticles in mega
voltage. Jain et al. (2011) has also used gold nanoparticles with glucose
coat (GLU-GNPs) as radio-sensitizer to improve radiotherapy in SK-OV-
Fig. 7. A) The Annexin-V/PI staining assay for detecting the apoptosis of LNCaP cells. B) The percentage of apoptosis and necrotic cells, 24 h after treatment with
PGPNPs and PGPNPs-FA only or combined with radiation 2, 4 or 6 Gy. (Mean ± SD, n= 3, statistical significance was showed with (*) P < 0.05, (**) P < 0.01 and
(***) for P < 0.001, respectively).
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3 ovary cells and the amount of reactive oxygen species was analyzed
by confocal microscopy [37]. They have evaluated induced apoptosis
via flow cytometry as well. Their results indicated that growth inhibi-
tion has increased 35.48 % and 26.88 % respectively in 90KVp and
6MV group using nanoparticles to compare with radiation alone. This
investigation has also showed that ionizing radiation with gold nano-
particles increased ROS production. Author stated that the effect of gold
nanoparticles on apoptosis amount in mega voltage energy is not
caused due to high atomic number of gold solely. Albeit gold nano-
particles can cause such effect through changing cell cycle and ceasing
cell in radio-sensitive phase of G2/M. In addition, ROS production in-
crease while radiation interaction with gold nanoparticles, is the main
mechanism of apoptosis induction in cancer cell [38]. In our study, acid
folic was used for cancer cell targeting as well as more specific treat-
ment and the results showed the effect of acid folic on clonogenic and
apoptotic cell death increase [39]. One the intrinsic characteristics of
some cancer cells is high expression of acid folic receptor in cell
membrane. Acid folic molecules can enter cells via protein carriers and
foliate reduced carriers apart from acid folic receptor endocytosis.
Huang et al. has prepared transonic particle (treatment-diagnose)
consist of gold nanotube as core, silica as stabilizer and folate as tar-
geting agent. The have conducted studies to evaluate radio-sensitizing
ability in cancer cells using gold nanoparticles-silica bounded folate.
The MGC803 cell gastric cancer was radiated by 6MV X-ray and cell
viability has gradually decreased with nanoparticles bounded folate
[3]. Therefore, the results of this paper were in agreement with pre-
vious results.
5. Conclusion
In this study, gold nanoparticles were used as a radio-sensitizer as
well as folic acid as targeting agent. Besides, due to the fluorescence
properties of the nanoparticles, their detection and tracing was con-
ducted by fluorescence microscopy. The results showed that gold na-
noparticles in mega -voltage energies and dosages of 2–6 grays could
exhibit radio-sensitizing effects. The use of folic acid as a targeting
agent was successful.
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